Endocrinol Metab.  2018 Sep;33(3):364-371. 10.3803/EnM.2018.33.3.364.

Calpain-10 and Adiponectin Gene Polymorphisms in Korean Type 2 Diabetes Patients

• Nam JS
• Han JW
• Lee SB
• You JH
• Kim MJ
• Kang S
• Park JS
• Ahn CW

• KMID: 2447026
• DOI: http://doi.org/10.3803/EnM.2018.33.3.364

Abstract

BACKGROUND
Genetic variations in calpain-10 and adiponectin gene are known to influence insulin secretion and resistance in type 2 diabetes mellitus. Recently, several single nucleotide polymorphisms (SNPs) in calpain-10 and adiponectin gene have been reported to be associated with type 2 diabetes and various metabolic derangements. We investigated the associations between specific calpain-10 and adiponectin gene polymorphisms and Korean type 2 diabetes patients.
METHODS
Overall, 249 type 2 diabetes patients and 131 non-diabetic control subjects were enrolled in this study. All the subjects were genotyped for SNP-43 and -63 of calpain-10 gene and G276T and T45G frequencies of the adiponectin gene. The clinical characteristics and measure of glucose metabolism were compared within these genotypes.
RESULTS
Among calpain-10 polymorphisms, SNP-63 T/T were more frequent in diabetes patients, and single SNP-63 increases the susceptibility to type 2 diabetes. However, SNP-43 in calpain-10 and T45G and intron G276T in adiponectin gene were not significantly associated with diabetes, insulin resistance, nor insulin secretion.
CONCLUSION
Variations in calpain-10, SNP-63 seems to increase the susceptibility to type 2 diabetes in Koreans while SNP-43 and adiponectin SNP-45, -276 are not associated with impaired glucose metabolism.

Keyword

Calpain 10; Adiponectin; Diabetes mellitus, type 2

MeSH Terms

Adiponectin*
Diabetes Mellitus, Type 2
Genetic Variation
Genotype
Glucose
Humans
Insulin
Insulin Resistance
Introns
Metabolism
Polymorphism, Single Nucleotide
Adiponectin
Glucose
Insulin

Reference

1. Kim WY, Kim JE, Choi YJ, Huh KB. Nutritional risk and metabolic syndrome in Korean type 2 diabetes mellitus. Asia Pac J Clin Nutr. 2008; 17(Suppl 1):47–51. PMID: 18296299.

2. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005; 365:1333–1346. PMID: 15823385.

3. Kifagi C, Makni K, Mnif F, Boudawara M, Hamza N, Rekik N, et al. Association of calpain-10 polymorphisms with type 2 diabetes in the Tunisian population. Diabetes Metab. 2008; 34:273–278. PMID: 18487065.

4. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M, et al. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet. 2001; 69:544–552. PMID: 11481585.

5. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, et al. Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes. 2002; 51:1644–1648. PMID: 11978669.

6. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ, et al. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab. 2002; 87:650–654. PMID: 11836299.

7. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003; 26:2442–2450. PMID: 12882876.

8. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 2002; 51:536–540. PMID: 11812766.

9. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes. 2002; 51:2325–2328. PMID: 12086969.

10. Song KE, Kim DJ, Park JW, Cho HK, Lee KW, Huh KB. Clinical characteristics of Korean type 2 diabetic patients according to insulin secretion and insulin resistance. J Korean Diabetes Assoc. 2007; 31:123–129.

11. Kim MJ, Yoo KH, Park HS, Chung SM, Jin CJ, Lee Y, et al. Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus. Yonsei Med J. 2005; 46:42–50. PMID: 15744804.

12. Lee YY, Lee NS, Cho YM, Moon MK, Jung HS, Park YJ, et al. Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population. Diabet Med. 2005; 22:569–575. PMID: 15842511.

13. Li LL, Kang XL, Ran XJ, Wang Y, Wang CH, Huang L, et al. Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin Exp Pharmacol Physiol. 2007; 34:1287–1290. PMID: 17973869.

14. Bacci S, Menzaghi C, Ercolino T, Ma X, Rauseo A, Salvemini L, et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care. 2004; 27:2015–2020. PMID: 15277433.

15. Yang WS, Yang YC, Chen CL, Wu IL, Lu JY, Lu FH, et al. Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr. 2007; 86:509–513. PMID: 17684226.

16. Marshall C, Hitman GA, Partridge CJ, Clark A, Ma H, Shearer TR, et al. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Mol Endocrinol. 2005; 19:213–224. PMID: 15471947.

17. Horikawa Y. Calpain-10 (NIDDM1) as a susceptibility gene for common type 2 diabetes. Endocr J. 2006; 53:567–576. PMID: 16873988.

18. Song Y, You NC, Hsu YH, Sul J, Wang L, Tinker L, et al. Common genetic variation in calpain-10 gene (CAPN10) and diabetes risk in a multi-ethnic cohort of American postmenopausal women. Hum Mol Genet. 2007; 16:2960–2971. PMID: 17855447.

19. Chen SF, Lu XF, Yan WL, Huang JF, Gu DF. Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population. Chin Med J (Engl). 2007; 120:2218–2223. PMID: 18167206.

20. Ezzidi I, Turki A, Messaoudi S, Chaieb M, Kacem M, Al-Khateeb GM, et al. Common polymorphisms of calpain-10 and the risk of type 2 diabetes in a Tunisian Arab population: a case-control study. BMC Med Genet. 2010; 11:75. PMID: 20470430.

21. del Bosque-Plata L, Aguilar-Salinas CA, Tusie-Luna MT, Ramirez-Jimenez S, Rodriguez-Torres M, Auron-Gomez M, et al. Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population. Mol Genet Metab. 2004; 81:122–126. PMID: 14741193.

22. Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, Phillips C, et al. Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes. 2002; 51:1622–1628. PMID: 11978665.

23. Picos-Cardenas VJ, Sainz-Gonzalez E, Miliar-Garcia A, Romero-Zazueta A, Quintero-Osuna R, Leal-Ugarte E, et al. Calpain-10 gene polymorphisms and risk of type 2 diabetes mellitus in Mexican mestizos. Genet Mol Res. 2015; 14:2205–2215. PMID: 25867367.

24. Chen Y, Kittles R, Zhou J, Chen G, Adeyemo A, Panguluri RK, et al. Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: the Africa America Diabetes Mellitus (AADM) Study. Ann Epidemiol. 2005; 15:153–159. PMID: 15652721.

25. Cox NJ, Hayes MG, Roe CA, Tsuchiya T, Bell GI. Linkage of calpain 10 to type 2 diabetes: the biological rationale. Diabetes. 2004; 53(Suppl 1):S19–S25. PMID: 14749261.

26. Daimon M, Oizumi T, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, et al. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract. 2002; 56:147–152. PMID: 11891023.

27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499–502. PMID: 4337382.

28. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet. 1996; 13:161–166. PMID: 8640221.

29. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000; 26:163–175. PMID: 11017071.

30. Yu SY, Ryu HK, Park HJ, Choi YJ, Huh KB, Kim WY. Adiponectin gene SNP 276G → T, nutrient intakes, and cardiovascular disease risk in Korean type 2 DM patients. Nutr Res Pract. 2007; 1:363–370. PMID: 20368963.

31. Zacharova J, Chiasson JL, Laakso M. STOP-NIDDM Study Group. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes. 2005; 54:893–899. PMID: 15734870.

32. Tripathy D, Eriksson KF, Orho-Melander M, Fredriksson J, Ahlqvist G, Groop L. Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in type 2 diabetes. Diabetologia. 2004; 47:782–793. PMID: 15114470.